MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Genetic risk of Parkinson’s disease in the general population

S. Darweesh, V. Verlinden, H. Adams, A. Uitterlinden, A. Hofman, B. Stricker, C. van Duijn, P. Koudstaal, M.A. Ikram (Rotterdam, Netherlands)

Meeting: 2016 International Congress

Abstract Number: 468

Keywords: Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Epidemiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: We investigated whether a genetic risk score for Parkinson’s disease (PD) is associated with the risk of incident PD, and whether the risk score improves prediction of PD. We also studied whether the risk score is associated with basic activities of daily living (BADL) in healthy individuals.

Background: Recent genome-wide association studies have identified 28 independent risk variants for PD, but their clinical relevance remains unknown.

Methods: Within the population-based Rotterdam Study, we genotyped 26 independent genetic risk variants for PD and constructed a genetic risk score in 7167 participants who were free of parkinsonism and dementia at baseline (1990 or 2000). Participants were followed for a maximum of twenty years for the onset of parkinsonism, dementia or death until January 1, 2011 (median follow-up 12.1 years). We used cox proportional hazard models and C-statistics to study the relationship between the genetic risk score and incident PD, adding the risk score to age, sex, smoking and parental history. In an independent sample of 2997 persons free of parkinsonism and dementia, we studied whether the PD risk genes were associated with impaired BADL.

Results: The genetic risk score was associated with incident PD (hazard ratio per standard deviation risk 1.25 [95% confidence interval=1.02;1.55]), but did not substantially improve prediction (change in C=0.01 [-0.011;0.03]).

Table 1. Prediction of incident Parkinson’s disease in the general population
  HR (95% CI) C-statistic (95% CI)
Model I   0.659 (0.599; 0.720)
Age 1.05 (1.03; 1.07)  
Female 0.66 (0.44; 0.98)  
     
Model II   0.687 (0.628; 0.745)
Age 1.05 (1.03; 1.07)  
Female 0.48 (0.30; 0.76)  
Smoking (past) 0.57 (0.35; 0.94)  
Smoking (current) 0.36 (0.18; 0.70)  
≥ 1 parent with PD 1.29 (0.40; 4.15)  
     
Model III   0.698 (0.635; 0.760)
Age 1.05 (1.02; 1.07)  
Female 0.48 (0.30; 0.76)  
Smoking (past) 0.57 (0.35; 0.93)  
Smoking (current) 0.36 (0.19; 0.71)  
≥ 1 parent with PD 1.25 (0.39; 4.03)  
Genetic risk score 1.25 (1.02; 1.55)  
HR, hazard ratio for incident Parkinson’s disease per standard deviation increase in risk score. CI, confidence interval. For smoking, the reference category was never.” The genetic risk score was associated with a higher probability of any impairment in BADL (odds ratio=1.11 [1.00;1.23]).

BADL N (%) OR (95%CI) P value
No impairment 461 (15.4) 1.000 (reference)  
Any impairment 2536 (84.6) 1.110 (1.002; 1.230) 0.047
Mild impairment 2017 (67.3) 1.123 (1.013; 1.246) 0.028
Moderate to severe impairment 519 (17.3) 1.020 (0.889; 1.171) 0.777
BADL, basic activities of daily living. N, number of persons. OR, odds ratio. 95%CI, 95% confidence interval. Odds ratio per standard deviation increase in genetic risk score. Reference category for both mild and moderate to severe impairment is no impairment. All analyses were adjusted for age, sex and smoking.“

Conclusions: Genetic variants for PD are associated with the risk of incident PD in the general population and with impairment in daily functioning in individuals without clinical parkinsonism, but do not improve the clinical prediction of PD.

(Still to be confirmed: 68th AAN Annual Meeting; April 15-21, 2016; Vancouver Convention Centre, Vancouver, BC, Canada). KEYWORDS: Parkinson’s disease, Genetic association study, Prediction, Epidemiology (none of these key words were listed in the next screen).

To cite this abstract in AMA style:

S. Darweesh, V. Verlinden, H. Adams, A. Uitterlinden, A. Hofman, B. Stricker, C. van Duijn, P. Koudstaal, M.A. Ikram. Genetic risk of Parkinson’s disease in the general population [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/genetic-risk-of-parkinsons-disease-in-the-general-population/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/genetic-risk-of-parkinsons-disease-in-the-general-population/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley